Presidio Pharmaceuticals Receives $6,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ad67ca36-a755-4ab5-bc87-56c722815d41&Preview=1 -
Date
12/21/2011 -
Company Name
Presidio Pharmaceuticals -
Mailing Address
1700 Owens Street San Francisco, CA 94158 -
Company Description
Presidio is focused on developing novel and established therapeutic modalities and small molecule compounds for the treatment of HIV-1, HCV and other chronic virus infections. -
Website
http://www.presidiopharma.com -
Transaction Type
Debt, Venture Equity -
Transaction Amount
$6,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
